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ation oAbstract Novel, simple, rapid and reliable High-Performance Thin-Layer Chromatographic
(HPTLC) and UV-spectroscopic area under curve (UV-AUC) methods were developed and vali-
dated for the analysis of zileuton racemate in bulk and in in-house tablet formulation. HPTLC
quantitation of zileuton was done by UV detection at 260 nm and analysis was performed on
(20 · 10 cm) aluminium sheets precoated with silica gel 60-F254 (E. Merck) as stationary phase
and toluene–methanol–glacial acetic acid (3.5:1.5:0.1 v/v) as mobile phase. Quantitation by HPTLC
method was performed over the concentration range of 200–1200 ng/band. The HPTLC method
resulted into a compact and well resolved band for zileuton at retention factor (Rf) of
0.51 ± 0.02. Linear regression analysis data for calibration of HPTLC method represented a good
linear relationship with regression coefﬁcient; r2 = 0.997. UV-AUC method was developed using
sodium lauryl sulphate (0.05 M) as a hydrotropic agent to enhance water solubility and area was
determined at a wavelength range in between 248.40 and 271.0 nm. Correlation coefﬁcient for
UV-AUC analysis was found to be r2 = 0.999. The developed UV-AUC method depicted a ﬁne lin-
ear relationship for zileuton racemate in a concentration range of 2–12 lg/mL. Both the developed
methods were validated for precision, robustness, ruggedness, accuracy, sensitivity as per guidelines
laid by the International Conference on Harmonisation (ICH). Statistical analysis proved that the
developed methods were precise, robust, sensitive and accurate and can be used effectively for the
analysis of zileuton in bulk and pharmaceutical formulations.
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Inﬂammatory diseases akin to psoriasis, rheumatoid arthritis,
asthma, multiple sclerosis, uveitis and inﬂammatory bowel
syndrome are implicated by leukotrienes produced via arachi-
donic acid metabolism by 5-lypoxygenase. These leukotrienes
(LT’s) are, unstable LTA4; followed by its sequential metabo-
lism to LTB4, LTC4, LTD4 and LTE4 (Rask-Madson et al.,
1992) which bind to the speciﬁc receptors in airways (Lewising Saud University.
. Novel HPTLC and UV-AUC analyses: For simple, econom-
Journal of Chemistry (2013), http://dx.doi.org/10.1016/
2 S.B. Ganorkar, A.A. Shirkhedkaret al., 1985). Zileuton R, S(±) N-(1-(benzo[b]-thien-2-
yl)ethyl)-N-hydroxyurea (Fig. 1) is a racemic mixture having
approximately equal therapeutic activities (Erdman, 1992).
Zileuton selectively and reversibly inhibits 5-lypoxygenase
activity and forms a complex with enzyme’s iron molecule in
the active site and inhibits calcium-ionophore-stimulated hu-
man neutrophil production of LTB4 after oral dosing (McGill
and Busse, 1996). Zileuton is a very slightly soluble compound
without any ionisable functional group (Qui et al., 1997) and
approved in the United States to treat asthma. A recent report
in the literature has emphasised review of zileuton as a new
efﬁcient and safe anti-acne drug (Zouboulis, 2009). Optimum
absorption for zileuton has been reported and majority of
the dose is recovered in the urine of healthy volunteers as
the N-hydroxyl glucuronides of both the R(+) and S() enan-
tiomers (Wong et al., 1995). Zileuton is metabolised in the
presence of NADPH3 (Awni et al., 1995a) and it is a weak
inhibitor of CYP1A2 (Lu et al., 2003). The drug has several
clinically important drug interactions such as inhibiting
warfarin and theophyline metabolism (Awni et al., 1995b;
Granneman et al., 1995a). Zileuton also showed a signiﬁcant
reduction in; inﬁltration of inﬂammatory cells and incidence
of hyperplasia (Yang et al., 2008).
Zileuton is ofﬁcial in the Unites States pharmacopeia (USP)
and its assay is proposed there in via HPLC with application of
ammonium acetate-acetohydroxamic acid buffer solution ad-
justed to pH 2.0 with perchloric acid and acetonitrile as a mo-
bile phase in a ratio of (72:28, v/v) (United States
Pharmacopeia 34-NF 29, 2011).
Literature survey revealed very critical, varied and atypical
reports for efﬁcient analytical determinations for zileuton
viz . . .Preparative separation and analysis of the enantiomers
of [14C] zileuton (Thomas and Surber, 1992a), Kinetics and
mechanism of chemical degradation in aqueous solutions by
HPLC (Thomas and Surber, 1992b), HPLC determination
with its N-dehydroxylated metabolite in plasma (Granneman
et al., 1995b), simultaneous determination along with N-dehy-
droxylated metabolite in untreated rat urine using HPLC
(Thomas and Albazi, 1996), electrochemical reduction behav-
iour of zileuton at a dropping mercury electrode by polarogra-
phy (Shreedhar et al., 2010) and one report on solubility and
stability characterisation of zileuton in a ternary solvent sys-
tem assisted with HPLC (Trivedi et al., 1996). The published
data depict no literature for the analysis of zileuton by High-
Performance Thin-Layer Chromatography (HPTLC) and sim-
ple UV-spectroscopy. The pharmacopeial method of analysis
by HPLC is supposed to use solvents in large quantities along
with higher concentrations of buffers in high proportion;
requiring greater time for the analytical determination and
may lead to some restrictions in analysis. On the other hand
developed HPTLC method will require lesser quantities of sol-
vents allowing cost-effective analysis with a provision to ana-
lyse large number of samples in a short period. ZileutonFigure 1 Chemical structure of zileuton.
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use a hydrotropic agent for the complete dissolution of drug
and to perform its UV-AUC analysis. A peak at 260 nm was
small; lacking sharpness and uniformity; so, to avoid any pos-
sible lacunae in spectroscopic analysis and to increase the
reproducibility and accuracy of the developed UV-AUC meth-
od we measured the uniform areas under the curves in between
wavelengths 248.40 and 271.0 nm. This might have assisted us
to detect the drug and develop its spectrophotometric method
at a low concentration range of 2–12 lg/mL again.
Hence, proposed investigation was intended to put forth
the establishment of a novel; simple, efﬁcient, rapid and eco-
nomical analysis of zileuton with application of HPTLC and
UV-AUC analyses to assist a routine quality control of zileu-
ton in bulk and pharmaceutical formulations.
2. Experimental
2.1. Drugs and reagents
Zileuton standard was obtained as a gift sample from Biophore
India Ltd. (Hyderabad, India), Methanol (HPLC Grade), So-
dium Lauryl Sulphate (SLS), Sodium Starch Glycolate
(SSG), and Microcrystalline Cellulose (MCC) used during the
study were procured from (Loba Chemie, India). Water used
for chromatography and spectroscopy was double-distilled
water and used throughout the experimental work described.
Tablets containing 600 mg of zileuton were prepared in-house.
2.2. Equipments and experimental conditions
2.2.1. For HPTLC analysis
A Camag TLC system (Muttenz, Switzerland) comprising of
Camag Linomat 5 automatic sample applicator, Hamilton syr-
inge (100 lL), Camag TLC scanner 3, Camag winCATS soft-
ware (version 1.3.0), Camag twin trough chamber (20 · 10 cm)
and ultrasonicator; ENERTECH Electronics Pvt. Ltd., India
was used during the study.
Chromatographic study was carried out on aluminium-
backed precoated silica gel 60-F254 (20 · 10 cm) HPTLC plates
having 200 lm thickness (E. Merck, Mumbai, India). Prior to
use; the HPTLC plates were pre-washed and dried in oven at
100 C. Densitometric detection was performed with a Camag
TLC Scanner 3 (Camag, Muttenz, Switzerland) installed with
winCATS software. Drug standards and samples were applied
on the HPTLC plates using Linomat 5 (Camag) applicator un-
der nitrogen gas ﬂow. Samples (10 lL) were spotted 6 mm
from the edge of the plates. The plates were developed in a
twin trough glass chamber (20 · 10 cm) (Camag, Muttenz,
Switzerland). The volume of the mobile phase was 10 mL. Mo-
bile phase components were mixed prior to use and the devel-
opment chamber was left for saturation with mobile phase
vapours for 20 min before each run at room temperature
(25 C± 2). Development of the plate was carried out by
the ascending technique to a migration distance of 8 cm fol-
lowed by drying with the help of an air drier. The slit dimen-
sions were kept at 6.00 · 0.45 mm (micro) and scanning
speed employed was 20 mm s1. Densitometric scanning was
done in absorbance–reﬂectance mode at 260 nm using a deute-
rium lamp emitting a continuous UV-spectrum between 190
and 400 nm. The slit dimensions were set at 6 mm.. Novel HPTLC and UV-AUC analyses: For simple, econom-
n Journal of Chemistry (2013), http://dx.doi.org/10.1016/
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A UV–Visible spectrophotometer (2450 Shimadzu, software
UV Probe 2.21) with a spectral bandwidth 1 nm was employed
for all spectroscopic measurements, using a pair of 10 mm
matched quartz cells. 0.05 M SLS was employed as solvent
for UV spectrophotometric determination of zileuton which
in particular has the advantage that it is also an ofﬁcial disso-
lution media for zileuton tablet formulation mentioned in USP
to predict the in vitro release characteristics of zileuton (United
States Pharmacopeia 34-NF 29, 2011).
SLS (0.05 M) was used as a hydrotropic agent and wetting
agent to enhance the solubility of poorly water soluble zileuton
racemate. Surfactant property of SLS assisted us to make the
drug completely soluble in double distilled water. SLS is well
known for its surfactant, wetting, spreading action and used
to assist dissolution of poorly water soluble drugs as well as
to predict in vitro release proﬁles of sparingly water soluble
drugs (Zonggui et al., 2004).
2.3. Preparation of standards
2.3.1. For HPTLC analysis
Zileuton 20 mg was weighed with assistance of SHIMADZU
AUX-120 analytical balance and dissolved in a 100 mL volu-
metric ﬂask containing 25 mL of methanol; sonicated for
10 min using ultrasonicator ENERTECH Electronics Pvt.
Ltd., India and the volume was made up to the mark to getFigure 2 Linearity studies for zileuton in toluene-methanol-glaci
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the standard solution, appropriate volumes of 1–6 mL were
transferred with the help of previously calibrated pipette
(10.0 mL) into a series of 10 mL volumetric ﬂasks. A ﬁxed vol-
ume of 10 lL was applied on the HPTLC plates to obtain con-
centrations 200, 400, 600, 800, 1000 and 1200 ng per band of
zileuton, respectively. Each concentration was applied six
times to the plates and plates were developed as described be-
fore in Section 2.2.1. Peak areas were plotted against their cor-
responding concentrations to obtain the calibration plot.2.3.2. For UV-AUC analysis
Zileuton is practically insoluble in water, 0.05 M SLS was em-
ployed as a solvent for complete dissolution of drug in water
and development of spectral characteristics of drug. SLS is
used as a hydrotropic agent to increase the solubility of very
slightly soluble zileuton in water. A stock standard solution
of zileuton was prepared by accurately weighing 10 mg of
zileuton as described in Section 2.3.1 followed by its dissolu-
tion in 25 mL 0.05 M SLS followed by sonication in ultrasoni-
cator for 15 min to remove the frothing produced if any and
the volume was made up to the mark very slowly by adding
0.05 M SLS to obtain a ﬁnal concentration of 100 lg/mL for
standard solution used during UV-AUC analysis. Care was ta-
ken and dilutions were made with very slow addition of 0.05 M
SLS to prevent the formation of foam and to avoid possible
ﬂaws in the analysis that may occur due to foam andal acetic acid (3.5:1.5:0.1 v/v) as mobile phase during HPTLC.
. Novel HPTLC and UV-AUC analyses: For simple, econom-
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Figure 3 Zero order spectrum of zileuton standard depicting
AUC in between 248.40 and 271.0 nm in 0.05 M SLS.
4 S.B. Ganorkar, A.A. Shirkhedkarentrapped air. After appropriate dilutions, 10 lg/mL zileuton
was scanned in the UV-region i.e., 400–200 nm.
2.4. Preparation of samples
Due to the unavailability of zileuton tablets in the local Indian
market, In-house tablets were formulated via direct compres-
sion technique using SSG and MCC containing 600 mg of
drug per tablet.
To determine the content of in-house prepared tablets of
Zileuton, twenty tablets were weighed as described before in
Section 2.3.1 and powdered in a glass mortar. An amount of
powder equivalent to 50 mg zileuton was transferred into
100 mL volumetric ﬂask containing 25 mL of methanol, soni-
cated for 20 min, and solution was diluted to volume with
same solvent. The resulting solution was ﬁltered through a
0.45 lm ﬁlter (Milliﬁlter, Milford, MA, USA).
For HPTLC determinations 8 lL from ﬁltrate was applied
on HPTLC plates to perform tablet assay for the drug.
For UV-spectroscopic determination an amount of pow-
der equivalent to 50 mg zileuton was transferred into
100 mL volumetric ﬂask containing 50 mL of 0.05 M SLS,
sonicated for 20 min and solution was diluted to volume
with same solvent and same precautions. The resulting solu-
tion was ﬁltered through a 0.45 lm ﬁlter slowly and a vol-
ume of ﬁltrate equal to 160 lL of solution was transferred
into 10 mL volumetric ﬂask and the volume was made up
to mark with 0.05 M SLS to obtain the ﬁnal concentration
of 8 lg/mL zileuton. The resulting solution was subjected
to the proposed method and the amount of zileuton present
was determined.Figure 4 Overlain spectra of linearity study during UV-AUC
analysis of zileuton in 0.05 M SLS.3. Results and discussion
The optimised HPTLC and UV-Spectroscopic-AUC methods
were validated as per standard procedures to ensure them for
linearity, precision, selectivity, sensitivity, robustness, accuracy
and speciﬁcity.
3.1. Development of optimum mobile phase
In order to obtain high resolution and reproducible peaks dif-
ferent mobile phase compositions were tested. The required
parameters were found optimum with use of toluene-metha-
nol-glacial acetic acid (3.5:1.5:0.1 v/v) as mobile phase. The
wavelength of 260 nm was found to be optimal for the highest
sensitivity. A sharp and well resolved peak was obtained for
zileuton at Rf of 0.51 ± 0.02 when the chamber was saturated
with mobile phase for 20 min at room temperature.
3.2. Linearity and calibration curve
Linearity study during HPTLC involved; use of 200 lg/mL of
zileuton as a stock standard and constant volume of 10 lL
were spotted on HPTLC plates to obtain 200, 400, 600, 800,
1000 and 1200 ng/band of zileuton, respectively. The calibra-
tion curve of area versus concentration was found to be linear
in the range of 200–1200 ng/band. Zileuton depicted a good
linear relationship of area against concentrations evaluated
during HPTLC analysis. Linear regression equation forPlease cite this article in press as: Ganorkar, S.B., Shirkhedkar, A.A. Novel HPTLC and UV-AUC analyses: For simple, econom-
ical, and rapid determination of Zileuton racemate. Arabian Journal of Chemistry (2013), http://dx.doi.org/10.1016/
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coefﬁcient (r2 = 0.997) which is generally considered as evi-
dence of acceptable ﬁt. The results are shown in Fig. 2.
UV-AUC method was validated for linearity by preparing
working standards from stock standard solution containing
100 lg/mL of zileuton to obtain solutions containing 2–
12 lg/mL of zileuton and scanned in UV region 400–200 nm
against blank solution of 0.05 M SLS. Zileuton showed maxi-
mum absorption (kmax) at 260 nm. Wavelengths 248.40 and
271 nm were selected for the measurement of area under curve
(AUC) Fig. 3. The calibration curve of AUC versus concentra-
tion was found to be linear in the range of 2–12 lg/mL. Linear
regression equation for UV-AUC was found to be
y = 0.176x+ 0.005 with regression coefﬁcient (r2 = 0.999).
Results are as quoted along with overlain spectra Fig. 4.
3.3. Precision
Repeatability and intermediate precision are two essential
components for the determination of precision during analyti-
cal method validation which indicates the ease of analysis for
the operator in a laboratory while striving to obtain same re-
sults for the same batch of material using same developed
method at a different time with application of same equip-
ments and reagents.
The intra-day and inter-day precisions of the HPTLC and
UV-AUC analyses were evaluated using linear regression data
for the calibration curve; analysing zileuton repeatedly at con-
centrations of 400, 800 and 1000 ng/band for HPTLC analysis
and 6, 8 and 10 lg/mL for UV-AUC determination. The pre-
cision of the developed HPTLC and UV-AUC methods is ex-
pressed in terms of percent relative standard deviation (%Table 2 Robustness for HPTLC analysis of zileuton racemate [n=
Conditions
n Mobile phase composition (±0.3 mL)
n Mobile phase volume (±2 mL)
n Development distance (±0.5 cm)
n Plate saturation time (±5 min)
n Relative humidity (±5%)
n Activation of HPTLC plates previously developed with methanol and
n Time from application to chromatography (±10 min)
n Time from chromatography to scanning (±10 min)
n – Number of estimations.
Table 1 Precision studies for zileuton racemate for HPTLC and U
Analysis Intra-day*
Drug Conc. (ng/band) Amount found (ng/band
HPTLC 400 399.84
800 792.6
1000 986.8
Drug Conc. (lg/mL) Amount found (lg/mL)
UV-AUC 6 5.99
8 8.12
10 9.84
* Mean of three estimations at each level.
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Results depicted optimum precision for both analyses and data
are represented as in Table 1.
3.4. Limits of detection and quantiﬁcation
The limit of detection (LOD) and limit of quantiﬁcation
(LOQ) determinations for both speciﬁed methods were based
on the standard deviations of the responses and slopes of con-
structed calibration curves (n= 3) as described by the Interna-
tional Conference for Harmonisation guidelines Q2(R1) (ICH,
1997, addendum incorporated 2005).
For the determination of LOD and LOQ during HPTLC
method validation; zileuton solutions of 200, 240, 280, 320,
360 and 400 ng/band were applied on HPTLC plates. Determi-
nation of LOD and LOQ for UV-AUC analysis involved use of
concentrations towards lower end; 2.0, 2.5, 3.0, 3.5 and 4.0 lg/
mL from the linearity range. The LOD and LOQ were calcu-
lated using equations LOD= 3.3 · N/B and LOQ= 10 · N/
B; Where, ‘N’ is standard deviation of peak areas of the drug
(n = 3) taken as a measure of noise and ‘B’ is the slope of cor-
responding calibration curve. As a result minimum concentra-
tions at which analyte can be reliably detected and quantiﬁed
were calculated and found to be 24 and 86 ng for HPTLC
and 0.45 and 1.46 lg for UV-AUC analysis, respectively.
3.5. Robustness
Robustness of an analytical method is a measure of its tendency
to confront deliberate variations in method parameters. The
robustness was demonstrated by performing test method in nor-
mal condition and each altered condition mentioned below.3].
Peak area ± SD RSD [%]
21.88 1.24
24.27 1.80
30.02 1.83
31.11 1.06
22.23 1.76
dried at 60 C (±2 min) 19.99 1.24
28.49 1.77
28.86 1.68
V-AUC analyses.
Inter-day*
) % RSD Amount found (ng/band) % RSD
0.99 386.4 1.01
0.53 789.4 0.98
0.46 984.2 0.89
% RSD Amount found (lg/mL) % RSD
1.21 6.12 1.83
1.72 8.14 1.39
1.36 10.06 1.84
. Novel HPTLC and UV-AUC analyses: For simple, econom-
Journal of Chemistry (2013), http://dx.doi.org/10.1016/
Figure 5 HPTLC chromatogram for zileuton standard in
toluene-methanol-glacial acetic acid (3.5:1.5:0.1 v/v) as mobile
phase.
Figure 6 UV-Spectra for comparison of zileuton standard an
6 S.B. Ganorkar, A.A. Shirkhedkar
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and the effects on the results were examined. Toluene: metha-
nol: glacial acetic acid in different ratios (3.2:1.8:0.2,
3.8:1.2:0.2, v/v) were selected (keeping volume of glacial acetic
acid same) and chromatograms were run. The amount of mo-
bile phase (10 ± 2 mL, i.e. 8, and 12 mL), development dis-
tance (8 ± 0.5 cm, i.e. 7.5 and 8.5 cm) and duration of
saturation (20 ± 5 min, i.e. 15, 20 and 25) were varied. Time
from application of zileuton to the plate to development of
the plate and time from development of plate to scanning were
also varied (10, 20, or 30 min) and results are depicted in
Table 2.d zileuton extracted from tablets during HPTLC analysis.
Table 3 Recovery studies for zileuton racemate for HPTLC
and UV-AUC analyses.
In-house
zileuton
tablets
(600 mg/tab)
Initial
amount
of drug
Amount of
standard
drug added
(%)
% Recovery
[n= 3]
% RSD
HPTLC 600 (ng/band) 80 99.89 1.80
100 100.4 0.98
120 100.2 1.33
UV-AUC 8 (lg/mL) 80 100.7 1.79
100 99.81 0.82
120 99.74 1.37
n – Number of estimations at each level.
. Novel HPTLC and UV-AUC analyses: For simple, econom-
n Journal of Chemistry (2013), http://dx.doi.org/10.1016/
Table 4 Summary of Regression, validation and in-house tablet formulation assay parameters for HPTLC and UV-AUC analyses.
Parameters RP-HPTLC UV-AUC
Regression coeﬃcient 0.997 0.999
Slope ± SD 2.432 ± 0.102 0.176 ± 0.006
Intercept ± SD 1560 ± 36.02 0.005 ± 0.001
Concentration range 200–1200 [ng/band] 2–12 [lg/ml]
Intra-day precision (n= 3, RSD,%) 0.66 1.43
Inter-day precision (n= 3, RSD,%) 1.23 1.68
Accuracy (n= 9, RSD,%) 100.16%; 1.37 99.87%; 1.32
LOD 24 ng 0.45 lg
LOQ 86 ng 1.46 lg
Robustness Robust Robust
Drug content 98.96 ± 1.84 99.84 ± 1.08
n – Number of estimations.
Novel HPTLC and UV-AUC analyses: For simple, economical, and rapid determination of Zileuton racemate 73.6. Accuracy
Accuracy of the methods was evaluated by spiking the drug at
three concentration levels 80%, 100% and 120% in a placebo
and determining the recovery of the drug added. The data for
recovery are represented in Table 3, good recoveries in the
range of 99.89% – 100.4% and 99.74% – 100.7% of the drug
were found after analysing by developed; HPTLC and UV-
AUC methods at various added concentrations, despite the
fact that the drug was fortiﬁed to a placebo consisting of
SSG and MCC.
3.7. Speciﬁcity for HPTLC
A typical absorption spectrum of zileuton is shown in Fig. 5.
The peak- purity of zileuton was tested by correlating the
spectra of zileuton added to placebo and zileuton standard
at the peak-start (S), peak-apex (A) and at the peak-end
(E) positions. Correlation between these spectra indicated
purity of zileuton peak {correlation r (S, M) = 0.9999, r (M,
E) = 0.9995} Fig. 6.
3.8. Ruggedness
Ruggedness of HPTLC method was performed at a concentra-
tion of 800 ng/band and for UV-AUC it was determined by
using drug at a concentration of 8 lg/mL. Methods were
found to be rugged when analysis was performed by two differ-
ent analysts under the same experimental and environmental
conditions.
3.9. Assay of in-house prepared zileuton tablets
A single peak at Rf of 0.51 ± 0.02 was observed in the chro-
matogram for zileuton during HPTLC analysis. There was
no interference observed from the excipients used in the formu-
lation of in-house zileuton tablets. The drug content ± SD
found for HPTLC analysis was 98.96 ± 1.84 and for UV-
AUC analysis it was found to be 99.84 ± 1.08.
The summary of regression, validation and in-house tablet
assay parameters is represented in Table 4 for developed
HPTLC and UV-AUC analyses.Please cite this article in press as: Ganorkar, S.B., Shirkhedkar, A.A
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